Just getting to the point of being ready to raise a Series A investment is no easy accomplishment, but that does not mean things get easier from this point on. Some sources say that only half of Seed Stage startups move on to raise a Series A. Join a panel featuring founders whom have successfully raised a Series A, Investors focused in the Series A landscape, and advisors whom work closely with countless start-ups raising money across the landscape.
Series A & Beyond
Anthony Millin is the Chair of NEXT and a trusted legal and business advisor to startup, early-stage and emerging growth companies. As a corporate and securities attorney, a successful serial entrepreneur and a venture capitalist, Anthony brings a unique legal and business perspective to advising his clients. “Anthony has had a tremendous impact on the success of my company since we were in the startup phase,” says Dale Nirvani Pfeifer, Founder and CEO of GoodWorld. “He has not only provided sound and creative legal support, but has also served as a key business advisor throughout the growth of my company.” Anthony understands firsthand what it takes to start, scale and manage a company, to successfully prepare for and run a fund raising process, and to address the legal issues faced by a startup. This background provides him with valuable insights into the legal and business needs of his clients. Anthony has worked closely with a range of angel and institutional investors and helps clients identify real opportunities. He serves businesses across multiple industries including internet/SaaS, technology, biotech, cleantech, edtech, fintech and health care. Another specialized skill set Anthony brings to the table is his China-based experience, assisting early-stage and middle-market companies interested in conducting business in China or seeking direct foreign investment from China. Anthony also serves as a Venture Partner at Urban.Us, a seed stage VC firm. Contact Anthony at [email protected].
Deepak Chhugani is the Founder & CEO at Nuvocargo.com, a logistics-tech startup modernizing the way companies move cargo across the Americas, starting with the world's biggest trade lane: US-Mexico trucking. Nuvocargo has raised over $5.3m from Silicon Valley investors such as NFX.com and Y Combinator, as well as Latin American venture funds such as ALLVP, Magma Partners, MAYA Capital, among others.
Deepak has also held positions in M&A investment banking at BofA Merrill Lynch focused on Latin America in both NYC and Mexico. He also has raised private equity capital to acquire over $20M of multifamily properties in southeast USA. Deepak was raised in Ecuador to Indian parents, and was born in Kenya.
Greg Merril is co-founder and CEO of Adaptive Phage Therapeutics, Inc, a clinical stage biotech based in Gaithersburg Maryland that has been named an “Emerging Life Science Company of the Year (2020)” by the Maryland Technology Council. Greg is a serial life-science entrepreneur, recognized by Ernst & Young as a regional Entrepreneur of the Year winner. He has served as Chair of several international phage therapy conferences. As prior founding CEO of Immersion Medical (NASDQ: IMMR) he led the creation of the world’s first commercially successful virtual reality surgical training simulators resulting in a company that was one of Maryland’s fastest revenue growth technology firms for four consecutive years. IMMR had peak market capitalization of over $1 billion. Greg has been recognized as a TEDMED Innovation Scholar for his work developing and commercializing head impact sensor technology to address the issue of sports-related traumatic brain injury. During his career Greg’s product developed efforts have been recognized twice as Innovation of the Year by the Consumer Electronic Association (CEA)/ Industrial Designers Society of America (IDSA). Other awards have included the 2015 International Sports Technology Award for Best Wearable Technology, and his previous company was selected as a Wall Street Journal Startup Company of the Year.
Mark Brenner is CEO and co-founder of WEST Technology, a subsidiary of Wiss. Wiss utilizes WEST technology to help early stage companies maintain a strong financial foundation, increase their probability of success, and obtain a return on sacrifice for founders and investors.
Prior to WEST, Mark founded three companies and ran them each as CEO to either a sale or IPO. Two of these companies have grown to over $100 million in revenue. He has over 13 years of venture capital and M&A investment banking experience, led a turnaround as interim CEO, and headed Corporate Partnerships for a public company. Overall, Mark had guided over 60 companies through investment transactions and exits before co-founding WEST.
Elizabeth is the Cofounder & Managing Director of MEDA Angels, a healthcare-focused angel investor group that she and a few physician-investor colleagues established. The Washington, DC-based MEDA Angels invests in mid-seed and Series A stage opportunities in health and wellness segments from across the country and on occasion, internationally. She is a trained cancer biologist with over 25 years cross-functional experience in academia, biotech and startups spanning drug development, preclinical studies - clinical trials, regulatory affairs, and capital raising. Elizabeth enjoys mentoring startups at incubators in the DC metropolitan area including Halcyon House, Johns Hopkins, Georgetown University and the Korea Innovation Center-DC, and frequently speaks at investment forums and judges startup pitch showcases. She received her BA from Johns Hopkins, her MS from Georgetown University, her PhD from Thomas Jefferson University, and completed her postdoctoral training in cancer epigenetics at the NIH & Harvard Medical School.
as of Sept 2020.